[C-283 in the treatment of pleural and peritoneal effusions in cases of ovarian cancer].
D000166:Acridines / Q000627:therapeutic use*; D001201:Ascites / Q000150:complications / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D009574:Nitro Compounds / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000150:complications*; D010996:Pleural Effusion / Q000150:complications / Q000188:drug therapy*; D011437:Propylamines / Q000627:therapeutic use; D012075:Remission, Spontaneous
D000166:Acridines; D009574:Nitro Compounds; D011437:Propylamines
Zwalczanie zwiazkiem C-283 wysieków otrzewnowych i opłucnowych u chorych z rakiem jajników.